BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 15035644)

  • 1. N-acetyl-p-benzoquinone imine, the toxic metabolite of acetaminophen, is a topoisomerase II poison.
    Bender RP; Lindsey RH; Burden DA; Osheroff N
    Biochemistry; 2004 Mar; 43(12):3731-9. PubMed ID: 15035644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cobalt enhances DNA cleavage mediated by human topoisomerase II alpha in vitro and in cultured cells.
    Baldwin EL; Byl JA; Osheroff N
    Biochemistry; 2004 Jan; 43(3):728-35. PubMed ID: 14730977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of topoisomerase II-mediated DNA cleavage by benzene metabolites.
    Lindsey RH; Bender RP; Osheroff N
    Chem Biol Interact; 2005 May; 153-154():197-205. PubMed ID: 15935817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,4-Benzoquinone is a topoisomerase II poison.
    Lindsey RH; Bromberg KD; Felix CA; Osheroff N
    Biochemistry; 2004 Jun; 43(23):7563-74. PubMed ID: 15182198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA topoisomerases as targets for the anticancer drug TAS-103: primary cellular target and DNA cleavage enhancement.
    Byl JA; Fortune JM; Burden DA; Nitiss JL; Utsugi T; Yamada Y; Osheroff N
    Biochemistry; 1999 Nov; 38(47):15573-9. PubMed ID: 10569941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of toxic metabolite formation of acetaminophen.
    Hazai E; Vereczkey L; Monostory K
    Biochem Biophys Res Commun; 2002 Mar; 291(4):1089-94. PubMed ID: 11866476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA topoisomerase II as the target for the anticancer drug TOP-53: mechanistic basis for drug action.
    Byl JA; Cline SD; Utsugi T; Kobunai T; Yamada Y; Osheroff N
    Biochemistry; 2001 Jan; 40(3):712-8. PubMed ID: 11170388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etoposide quinone is a redox-dependent topoisomerase II poison.
    Jacob DA; Mercer SL; Osheroff N; Deweese JE
    Biochemistry; 2011 Jun; 50(25):5660-7. PubMed ID: 21595477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of cysteine residue 455 to alanine in human topoisomerase IIalpha confers hypersensitivity to quinones: enhancing DNA scission by closing the N-terminal protein gate.
    Bender RP; Osheroff N
    Chem Res Toxicol; 2007 Jun; 20(6):975-81. PubMed ID: 17516663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of topoisomerase II-targeted anticancer agents reflects the persistence of drug-induced cleavage complexes in cells.
    Bandele OJ; Osheroff N
    Biochemistry; 2008 Nov; 47(45):11900-8. PubMed ID: 18922022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantum chemical study of the reactivity of acetaminophen (paracetamol) toxic metabolite N-acetyl-p-benzoquinone imine with deoxyguanosine and glutathione.
    Klopčič I; Poberžnik M; Mavri J; Dolenc MS
    Chem Biol Interact; 2015 Dec; 242():407-14. PubMed ID: 26551927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic core of human topoisomerase IIα: insights into enzyme-DNA interactions and drug mechanism.
    Lindsey RH; Pendleton M; Ashley RE; Mercer SL; Deweese JE; Osheroff N
    Biochemistry; 2014 Oct; 53(41):6595-602. PubMed ID: 25280269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of C1-O-substituted-3-(3-butylamino-2-hydroxy-propoxy)-xanthen-9-one as topoisomerase IIα catalytic inhibitors.
    Park S; Hong E; Kwak SY; Jun KY; Lee ES; Kwon Y; Na Y
    Eur J Med Chem; 2016 Nov; 123():211-225. PubMed ID: 27484510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exocyclic DNA lesions stimulate DNA cleavage mediated by human topoisomerase II alpha in vitro and in cultured cells.
    Vélez-Cruz R; Riggins JN; Daniels JS; Cai H; Guengerich FP; Marnett LJ; Osheroff N
    Biochemistry; 2005 Mar; 44(10):3972-81. PubMed ID: 15751973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributions of the D-Ring to the activity of etoposide against human topoisomerase IIα: potential interactions with DNA in the ternary enzyme--drug--DNA complex.
    Pitts SL; Jablonksy MJ; Duca M; Dauzonne D; Monneret C; Arimondo PB; Anklin C; Graves DE; Osheroff N
    Biochemistry; 2011 Jun; 50(22):5058-66. PubMed ID: 21548574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioflavonoids as poisons of human topoisomerase II alpha and II beta.
    Bandele OJ; Osheroff N
    Biochemistry; 2007 May; 46(20):6097-108. PubMed ID: 17458941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,2-Naphthoquinone as a Poison of Human Type II Topoisomerases.
    Collins JA; Osheroff N
    Chem Res Toxicol; 2021 Apr; 34(4):1082-1090. PubMed ID: 33760604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-source formation of N-acetyl-p-benzoquinone imine (NAPQI), the putatively toxic acetaminophen (paracetamol) metabolite, after derivatization with pentafluorobenzyl bromide and GC-ECNICI-MS analysis.
    Tsikas D; Trettin A; Zörner AA; Gutzki FM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(17-18):1476-84. PubMed ID: 21353649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polychlorinated biphenyl quinone metabolites poison human topoisomerase IIalpha: altering enzyme function by blocking the N-terminal protein gate.
    Bender RP; Lehmler HJ; Robertson LW; Ludewig G; Osheroff N
    Biochemistry; 2006 Aug; 45(33):10140-52. PubMed ID: 16906772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
    Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.